candesartan has been researched along with Brain Vascular Disorders in 5 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Head-to-head comparison suggests that treatment with aliskiren before and during cerebral ischemia is at least as effective as candesartan in double transgenic rats." | 7.76 | Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes. ( Culman, J; Hocher, B; Mueller, S; Muller, DN; Pfab, T; Schmerbach, K; Thoene-Reineke, C; Unger, T; Villringer, A; Zhao, Y, 2010) |
| "Head-to-head comparison suggests that treatment with aliskiren before and during cerebral ischemia is at least as effective as candesartan in double transgenic rats." | 3.76 | Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes. ( Culman, J; Hocher, B; Mueller, S; Muller, DN; Pfab, T; Schmerbach, K; Thoene-Reineke, C; Unger, T; Villringer, A; Zhao, Y, 2010) |
| "Diabetes and hypertension are potent risk factors for cerebrovascular disease." | 1.33 | Diabetic brain damage in hypertension: role of renin-angiotensin system. ( Eguchi, K; Hoshide, S; Ishikawa, J; Ishikawa, S; Kario, K; Matsui, Y; Morinari, M; Shimada, K, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmerbach, K | 1 |
| Pfab, T | 1 |
| Zhao, Y | 1 |
| Culman, J | 1 |
| Mueller, S | 1 |
| Villringer, A | 1 |
| Muller, DN | 1 |
| Hocher, B | 1 |
| Unger, T | 1 |
| Thoene-Reineke, C | 1 |
| Kario, K | 1 |
| Ishikawa, J | 1 |
| Hoshide, S | 1 |
| Matsui, Y | 1 |
| Morinari, M | 1 |
| Eguchi, K | 1 |
| Ishikawa, S | 1 |
| Shimada, K | 1 |
| Nakamura, T | 1 |
| Honma, H | 1 |
| Ikeda, Y | 1 |
| Kuroyanagi, R | 1 |
| Takano, H | 1 |
| Obata, J | 1 |
| Sato, T | 1 |
| Kimura, H | 1 |
| Yoshida, Y | 1 |
| Tamura, K | 1 |
| Bennai, F | 1 |
| Morsing, P | 1 |
| Paliege, A | 1 |
| Ketteler, M | 1 |
| Mayer, B | 1 |
| Tapp, R | 1 |
| Bachmann, S | 1 |
| Saavedra, JM | 1 |
| Nishimura, Y | 1 |
1 review available for candesartan and Brain Vascular Disorders
| Article | Year |
|---|---|
Angiotensin and cerebral blood flow.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimid | 1999 |
4 other studies available for candesartan and Brain Vascular Disorders
| Article | Year |
|---|---|
Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes.
Topics: Amides; Angiotensinogen; Animals; Animals, Genetically Modified; Antihypertensive Agents; Benzimidaz | 2010 |
Diabetic brain damage in hypertension: role of renin-angiotensin system.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aspartic Acid; Benzimidazoles; Biphenyl Compounds; Bl | 2005 |
Renal protective effects of angiotensin II receptor I antagonist CV-11974 in spontaneously hypertensive stroke-prone rats (SHR-sp).
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cereb | 1994 |
Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Animals; Arterioles; Benzimidazoles; Biphenyl Compounds; Blood Pre | 1999 |